APA (7th ed.) Citation

Mingjun Rui, Mingjun Rui, Zijing Wang, Zijing Wang, Zhengyang Fei, Zhengyang Fei, . . . Hongchao Li. (2022). The Relationship Between Short-Term Surrogate Endpoint Indicators and mPFS and mOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non-Small-Cell Lung Cancer in China. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Mingjun Rui, et al. The Relationship Between Short-Term Surrogate Endpoint Indicators and MPFS and MOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non-Small-Cell Lung Cancer in China. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Mingjun Rui, et al. The Relationship Between Short-Term Surrogate Endpoint Indicators and MPFS and MOS in Clinical Trials of Malignant Tumors: A Case Study of Approved Molecular Targeted Drugs for Non-Small-Cell Lung Cancer in China. Frontiers Media S.A., 2022.